Cooper

Mr. Weiss has served as our President since March 2008 and as our Chief Executive Officer since November 2007. He also served as President of CooperVision, our contact lens subsidiary from March 2007 to February 2008. He previously served as our Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as our Chief Financial Officer from September 1989 to January 2005. He also served as our Treasurer from 1989 to March 2002. Since joining us in 1977, he has held a number of finance positions both with us and Cooper Laboratories, Inc. (our former parent). Mr. Weiss is also a director of Accuray Incorporated, a company that develops and markets a sophisticated robotic radiosurgery system designed to treat tumors, and serves on its Nominating Committee and as Chair of its Audit Committee.

Laura A. Cribbins is Senior Validation Manager with William Trilsch & Associates. She has over fifteen years of experience in the field of pharmaceutical R & D and validation management. She also contributes in the areas of strategic planning, and project management. Her bachelor's degree is in Biology (UC Santa Cruz) and she holds an MBA from Santa Clara University. Ms. Cribbins was Director of West Coast Operations for Certipharm, a company specializing in validation and calibration services and Senior Manager/Director of Business Development with Validation Systems, Inc. She has additional experience with Coalesce Corporation, Arnett Associates, Biotrack, Inc. and The Cooper Companies. Ms Cribbins provides in depth experience in validation master planning, protocol development and execution, report writing and consulting expertise on a wide range of validation and related FDA issues. She has worked on and managed validation projects throughout North America and Europe and successfully prepared several pharmaceutical manufacturers for Pre-Approval inspections. Ms. Cribbins is a member of the Northern California Pharmaceutical Discussion Group (NCPDG) where she was an officer during the period 1985-1987. She is also a member of the Parenteral Drug Association, and the Association of Women in Science.

Stephen F. Cooper became our Chief Executive Officer in February 2008, bringing more than 35 years of management leadership experience to the role. Mr. Cooper is chairman of Kroll Zolfo Cooper LLC (KZC), a leading financial advisory and interim management firm, where he has extensive experience improving business operations for companies. He assumed the chairman position at KZC in September 2002, when Kroll Inc. acquired Zolfo Cooper, LLC, the corporate recovery and crisis management firm that Mr. Cooper co-founded in 1985. Mr. Cooper also is currently providing management services to American Home Mortgage Investment Corp. Mr. Cooper previously served as CEO of Krispy Kreme Doughnuts, Inc. in 2005, and as interim CEO and Chief Restructuring Officer of Enron Corp. from 2002 to 2005.